MarketPulse
C

$CURX

2 articles found
1 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Schall Law Firm

Curanex Pharma Under Fire: Law Firm Probes $CURX for Alleged Securities Violations

Schall Law Firm investigates $CURX for potential securities fraud, alleging false statements and material disclosure failures. Harmed shareholders invited to participate.
CURXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Curanex Advances Phyto-N Toward Late-Stage Development as Clinical Timeline Solidifies

Curanex advances Phyto-N toward IND submission in Q4 2026, completing manufacturing and toxicology milestones with secured 12-month funding.
CURXclinical trialspharmaceutical development